
|Articles|February 28, 2014
Proteomics International Partners with inVentiv Health Clinical
Proteomics International Partners with inVentiv Health Clinical
Advertisement
Proteomics International, a pretomics laboratory, has signed a collaborative agreement with inVentiv Health Clinical, provider of global research and bioanalytical services, with the intention of helping streamline the process from characterization to clinical trials.
Proteomics International's structural characterization and QC testing of proposed and referenced products with an advanced suite of scientific instrumentation complement inVentiv Health’s array of bioanalytical capabilities from clinical development through commercialization in support of biosimilar development.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5



